Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The $50 copay does not count toward the deductible or out-of-pocket cap, and Extra Help cannot be applied to Bridge claims
Through real-world case studies, we discuss how structure-based strategies used by medicinal chemists have successfully reduced phototoxic risk and positively impacted medicinal chemistry projects
To obtain additional restraints for structural model determination of the p53 TAD2 -FOXO4 FH complex, we determined paramagnetic relaxation enhancements (PREs) for a set of 7 complexes containing spin-labeled (SL) samples ( 15 N-labeled FOXO4 FH + S46C-SL p53 TAD2 , 15 N-labeled FOXO4 FH + Q52C-SL p53 TAD2 , 15 N-labeled p53 TAD2 + Q112C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + D140C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + N145C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + S159C-SL FOXO4 FH , 15 N-labeled p53 TAD2 + S162C-SL FOXO4 FH )
A recent 2021 study by Cunningham et al
These medications are contraindicated in people with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
.png.jpg)
US$ 22.43
US$ 27.57
US$ 27.21
US$ 21.25
US$ 20.52
US$ 22.82
